chr8-67149784-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001382391.1(CSPP1):​c.1977T>C​(p.Thr659Thr) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00136 in 1,534,256 control chromosomes in the GnomAD database, including 25 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0078 ( 13 hom., cov: 32)
Exomes 𝑓: 0.00066 ( 12 hom. )

Consequence

CSPP1
NM_001382391.1 splice_region, synonymous

Scores

2
Splicing: ADA: 0.001318
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 2.16

Publications

0 publications found
Variant links:
Genes affected
CSPP1 (HGNC:26193): (centrosome and spindle pole associated protein 1) This gene encodes a centrosome and spindle pole associated protein. The encoded protein plays a role in cell-cycle progression and spindle organization, regulates cytokinesis, interacts with Nephrocystin 8 and is required for cilia formation. Mutations in this gene result in primary cilia abnormalities and classical Joubert syndrome. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Apr 2014]
CSPP1 Gene-Disease associations (from GenCC):
  • Joubert syndrome 21
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • Joubert syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Joubert syndrome with Jeune asphyxiating thoracic dystrophy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Meckel syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 8-67149784-T-C is Benign according to our data. Variant chr8-67149784-T-C is described in ClinVar as Benign. ClinVar VariationId is 474852.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.16 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00776 (1182/152232) while in subpopulation AFR AF = 0.0271 (1127/41542). AF 95% confidence interval is 0.0258. There are 13 homozygotes in GnomAd4. There are 553 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 13 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CSPP1NM_001382391.1 linkc.1977T>C p.Thr659Thr splice_region_variant, synonymous_variant Exon 18 of 31 ENST00000678616.1 NP_001369320.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CSPP1ENST00000678616.1 linkc.1977T>C p.Thr659Thr splice_region_variant, synonymous_variant Exon 18 of 31 NM_001382391.1 ENSP00000504733.1 A0A7I2V5W3

Frequencies

GnomAD3 genomes
AF:
0.00774
AC:
1178
AN:
152114
Hom.:
13
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0271
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00216
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00767
GnomAD2 exomes
AF:
0.00189
AC:
375
AN:
198118
AF XY:
0.00150
show subpopulations
Gnomad AFR exome
AF:
0.0278
Gnomad AMR exome
AF:
0.000405
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000205
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.000660
AC:
912
AN:
1382024
Hom.:
12
Cov.:
30
AF XY:
0.000611
AC XY:
419
AN XY:
685634
show subpopulations
African (AFR)
AF:
0.0271
AC:
799
AN:
29486
American (AMR)
AF:
0.000913
AC:
27
AN:
29574
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23002
East Asian (EAS)
AF:
0.0000270
AC:
1
AN:
37022
South Asian (SAS)
AF:
0.0000281
AC:
2
AN:
71192
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51446
Middle Eastern (MID)
AF:
0.000556
AC:
3
AN:
5400
European-Non Finnish (NFE)
AF:
0.00000371
AC:
4
AN:
1078316
Other (OTH)
AF:
0.00134
AC:
76
AN:
56586
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
39
78
116
155
194
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00776
AC:
1182
AN:
152232
Hom.:
13
Cov.:
32
AF XY:
0.00743
AC XY:
553
AN XY:
74436
show subpopulations
African (AFR)
AF:
0.0271
AC:
1127
AN:
41542
American (AMR)
AF:
0.00216
AC:
33
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10600
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
68022
Other (OTH)
AF:
0.00759
AC:
16
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
56
113
169
226
282
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00303
Hom.:
6
Bravo
AF:
0.00844
Asia WGS
AF:
0.00145
AC:
5
AN:
3472

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Jul 31, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Joubert syndrome 21 Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.48
CADD
Benign
14
DANN
Benign
0.65
PhyloP100
2.2
Mutation Taster
=63/37
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0013
dbscSNV1_RF
Benign
0.080
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs114177619; hg19: chr8-68062019; API